Month: July 2022

13th Annual Rush Alzheimer’s Disease Center Meeting

Dr. Goodenowe presents at the 13th Annual Rush Alzheimer’s Disease Center ROSMAP Investigator’s Meeting 2022 at the Rush University Medical Center in Chicago, IL. Dr. Goodenowe presents on Tuesday, July 12, 2022; his presentation is titled Plasmalogens, Neuropathology, and Cognition – Update on Recent Advances and Overview of MARS Project.  The Religious Orders Study/Memory and …

13th Annual Rush Alzheimer’s Disease Center Meeting Read More »

ProdromeNeuro Alzheimer’s Clinical Trial Published

The results from our clinical trial with Dr. Sheldon Jordan are now published in a peer reviewed journal here. ProdromeNeuroTM plasmalogen supplement successfully improved cognition and mobility in a recent Alzheimer’s disease clinical trial, proving Dr. Dayan Goodenowe’s 15-year theory outlined in his new book Breaking Alzheimer’swhere he explains his scientific journey to expose the …

ProdromeNeuro Alzheimer’s Clinical Trial Published Read More »